s6y
Company name or ticker
Search
ARS Pharmaceuticals, Inc.
4
Slebir John L: Statement of changes in beneficial ownership of securities
Filed
Wednesday, November 4, 2026
Period
Nov 2, 2026
Accession number
0001475990-26-000009
Documents
form4-11042026_091100.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header